Awaiting product image

Factor Xiii Activity (Qualitative)

₹1,000.00

15 minutes
Categories: ,

The Factor XIII Activity (Qualitative) Test measures the activity of Factor XIII, a critical clotting factor in the blood coagulation cascade. Factor XIII, also known as fibrin-stabilizing factor, plays an essential role in stabilizing blood clots by crosslinking fibrin threads, thus making the clot more durable and resistant to early breakdown. Without sufficient activity of Factor XIII, blood clots may dissolve too quickly, leading to abnormal bleeding.
The qualitative test assesses whether Factor XIII is functioning adequately, often by measuring the clot’s ability to resist dissolution when exposed to certain chemicals (like 5M urea). If the clot dissolves quickly, it suggests low or absent Factor XIII activity, indicating a Factor XIII deficiency

Enquiry Here

    Description

    Why It’s Done:

    The Factor XIII Activity (Qualitative) Test is performed for several reasons:
    • Diagnosing Factor XIII deficiency: This test is primarily used to diagnose Factor XIII deficiency, a rare bleeding disorder that leads to an increased risk of bleeding or spontaneous bleeding episodes, particularly in the absence of trauma or injury. Factor XIII deficiency is associated with delayed bleeding after injuries and surgeries.
    • Evaluating unexplained bleeding or bruising: If a patient experiences recurrent bleeding episodes, especially those that occur without obvious trauma, or prolonged bleeding after surgery, this test can help identify whether a Factor XIII deficiency is contributing to the bleeding problem.
    • Assessing recurrent miscarriages: In some cases, Factor XIII deficiency has been linked to recurrent miscarriages, and this test may be performed in women with a history of multiple pregnancy losses.
    • Monitoring treatment in known Factor XIII deficiency: For individuals diagnosed with Factor XIII deficiency, this test can be used to monitor the effectiveness of treatments such as Factor XIII concentrate therapy.
    • Differentiating from other clotting disorders: It can help distinguish Factor XIII deficiency from other clotting disorders, such as Hemophilia A, Hemophilia B, or von Willebrand disease, where bleeding issues arise due to different mechanisms.

    Preparation:

    • Fasting: Fasting is not required for this test.
    • Medications: It’s important to inform your healthcare provider about any medications or treatments you are currently taking, especially blood thinners (e.g., warfarin, heparin), as they can affect the clotting process and may interfere with the results.
    • Blood Sample: The test requires a blood sample, usually drawn from a vein in your arm. A small amount of blood will be taken for analysis.
    • Timing: If you are undergoing treatment for a bleeding disorder or receiving Factor XIII supplementation, the timing of the test might need to be coordinated with your treatment schedule to ensure an accurate assessment of Factor XIII activity.
    • Recent Illness or Surgery: It’s essential to inform your healthcare provider if you have recently had surgery, trauma, or an illness, as these can affect clotting factors and might influence the results of the test

    Related products